You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors
|
---|---|
Published in |
Prostate Cancer and Prostatic Diseases, July 2023
|
DOI | 10.1038/s41391-023-00696-w |
Pubmed ID | |
Authors |
Georges Gebrael, Nicolas Sayegh, Vinay Mathew Thomas, Beverly Chigarira, Nishita Tripathi, Yeon Jung Jo, Haoran Li, Kamal Kant Sahu, Ayana Srivastava, Taylor McFarland, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal |
X Demographics
The data shown below were collected from the profiles of 66 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 23 | 35% |
Brazil | 3 | 5% |
Spain | 3 | 5% |
Switzerland | 2 | 3% |
United Kingdom | 2 | 3% |
Colombia | 2 | 3% |
France | 1 | 2% |
Argentina | 1 | 2% |
Mexico | 1 | 2% |
Other | 9 | 14% |
Unknown | 19 | 29% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 38 | 58% |
Practitioners (doctors, other healthcare professionals) | 14 | 21% |
Scientists | 13 | 20% |
Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 4 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 1 | 25% |
Unknown | 3 | 75% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 1 | 25% |
Unknown | 3 | 75% |
Attention Score in Context
This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2023.
All research outputs
#1,089,957
of 25,934,224 outputs
Outputs from Prostate Cancer and Prostatic Diseases
#51
of 1,260 outputs
Outputs of similar age
#20,036
of 356,214 outputs
Outputs of similar age from Prostate Cancer and Prostatic Diseases
#1
of 19 outputs
Altmetric has tracked 25,934,224 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,260 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,214 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.